Rising Tide Q4’2021 Newsletter

*|MC:SUBJECT|*

Dear Esteemed Partners and Friends:

It has been a wonderful year – as innovative, exciting, and progressive as one would hope. Brilliant entrepreneurs we seed-financed in the last five years are leading 70+ companies in promising, innovative verticals including Artificial Intelligence, FinTech, Blockchain, Digital Communication, Personalized Medicine, and Sustainability. The overwhelming majority are on a fast track, having raised $2.5B+ in follow-on financing to accelerate growth and international expansion. We are excited to continue backing standout performers in future rounds. Highlights are briefly summarized below. 

DAPPER LABS RAISES $600M+. NBA TOP SHOT GROWS BY 100X IN 2021, WITH MORE THAN $700M IN COLLECTIBLES BOUGHT AND SOLD
As 2021 ended, crypto gaming giant Dapper Labs published an overall review of its several high-profile projects. One of its major creations is the NBA Top Shot that has grown more than 100x — to over a million signups and 150,000 active users to date. Similarly, community consisting of Web3 developers building on the Flow blockchain has also increased by 100x. Established firms have dived into the Flow ecosystem - YouTube choosing Flow as their first NFT minting platform, rewarding gifts to their top creators that are starting to make the rounds on the social. More here.  

FOR COINLIST, 2021 HAS BEEN A BREAKTHROUGH YEAR
CoinList helped dozens of the world’s best crypto projects get more high-value users; increased its user base by 42x globally; successfully expanded into trading, staking, and lending; tripled the size of its team; and raised $100M at a valuation of $1.5B that sets up the company for further success. Learn more here

TRIBAL RAISES $40M IN CRYPTO-TRADFI TO POWER PAYMENTS AND FINANCING FOR LATAM SMBs 
Tribal is a B2B payment and financing platform for emerging markets. The debt round is to assist Tribal expand its financing and payment services for small and medium-sized businesses (SMBs) to new countries in Latin America. The debt round closes at a moment of major development and momentum for Tribal, which has experienced more than 50x growth in LatAm since early 2021, serving customers in Mexico, Chile, Peru, Colombia, and Brazil. More here 

MESSARI RAISES $21M IN SERIES A 
Messari is building the cryptoasset industry's most reliable disclosures library and data analytics platform. The investment will help the company expand the global reach of its Pro and Enterprise product suites, triple the size of its engineering and research teams, and introduce new offerings that streamline participation in decentralized projects and their communities. Learn more here

ASTRANIS EXPANDING FROM ALASKA TO LATIN AMERICA  
Astranis, a San Francisco-based Unicorn company with an alternative approach to providing internet access from satellites, announced a deal that will bring broadband to millions of people in Peru in two years. The Company’s agreement with Latin American service provider Grupo Andesat will see Astranis deploy one of its small form factor satellites specifically for Peru. Astranis sees this Andesat deal as a model they can replicated across Latin America. The estimated value of the Andesat deal is over $90M. More here

QUANERGY DELIVERS INDUSTRY FIRST 200 METER RANGE LIDAR 
Quanergy Systems announced its successful Optical Phased Array LiDAR out to a range of 200 meters. This doubles the range achieved earlier in the year and further expands the set of applications the technology can address through its S3 Series LiDAR, a true solid state sensor using an industry-first, scalable CMOS silicon manufacturing process for cost-effective, mass-market production. Applications expanded from autonomous vehicles to traffic flow management, public transportation safety, smart cities, crowd flow management, and security. Services are deployed across the world from San Francisco to France to Korea. More here.  

SOLARIO BIO RAISES $11.2M SERIES A 
Solarea Bio is a biotechnology company developing new microbiome-based solutions to some of the world's largest health problems. The financing will advance its musculoskeletal product through a clinical proof of activity trial as well as continue the discovery and development of its ongoing pipeline of microbial-based products for human health and well-being. Learn more here

ACTIV SURGICAL COMPLETES FIRST IN-HUMAN PROCEDURES TO DEMONSTRATE IMPACT OF ITS SURGICAL INTELLIGENCE AND SENSING PLATFORM
Activ Surgical completed its first in-human surgery clinical trial utilizing the company’s technology-as-a-service bundle – the ActivInsights augmented reality-based software suite and the ActivSight imaging module. The safety and feasibility study were conducted across surgeries in which intraoperative assessment of perfusion and anatomic structures are critical to prevent costly and life-threatening complications. The company received Food and Drug Administration (FDA) clearance for the ActivSight interoperable imaging module in April 2021 and expects its software suite to be commercially available to surgeons around the world in 2022. Learn more here

STAKED ACQUIRED TO SUPPORT GROWTH AND RESILIENCE IN ONE OF LARGEST CRYPTO INDUSTRY DEALS TO DATE 
Kraken, one of the world's largest digital asset platforms, announced it has acquired Staked, a Rising Tide portfolio company, in one of the largest crypto industry acquisitions to date. “We are excited to add Staked to our portfolio of yield products, which has seen great uptake by a growing population of crypto investors,” said Jesse Powell, CEO, and co-founder of Kraken. “Staked is highly complementary to our existing staking business and will allow us to further strengthen our product offering through world-class infrastructure for clients who prefer to retain custody of their staked assets. We’re excited to welcome Staked clients to Kraken and believe that they will benefit from access to our wider portfolio of products as they seek to broaden their engagement with digital assets.”  Learn more here

ULTRASOUND DISRUPTOR EXO SECURES $220M IN SERIES C ROUND 
Exo is a health information and devices company and believes everyone around the world should have access to high-quality, affordable, and easy-to-use medical imaging. Exo’s goal is to enable healthcare professionals to make critical, real-time decisions that improve patient outcomes. The company recently closed a $220M Series C investment round that will fund the commercialization of its handheld ultrasound device and its intuitive point-of-care ultrasound workflow solution, Exo Works. Learn more here.  

Disclosure: This presentation is not an offer to sell securities of any investment fund or a solicitation of offers to buy any such securities. Securities of any fund (the “Fund”) managed by Rising Tide Fund Managers, LLC (the “Rising Tide”) are offered to selected investors only by means of a complete offering memorandum and related subscription materials which contain significant additional information about the terms of an investment in the Fund (such documents, the “Offering Documents”). The portfolio companies described herein do not represent all the portfolio companies purchased, sold or recommended for portfolios advised by Rising Tide. The reader should not assume that an investment in the portfolio companies identified were or will be profitable. Past performance is not indicative of future results. Investors should be aware that a loss of investment is possible. The information in this presentation was prepared by Rising Tide and is believed to be reliable. Rising Tide makes no representation as to the accuracy or completeness of such information. Opinions, estimates and projections in this presentation constitute the current judgment of Rising Tide and are subject to change without notice.

Twitter
LinkedIn
Website